BV
BioMed Ventures
San Diego, California, United StatesFounded 2010
BioMed Ventures, an investment arm of BioMed Realty, was a life science venture capital group that focused its investments on the biotechnology, medical, and diagnostics sectors.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (40% of deals). Average disclosed round size is $40.4M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
$200M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPrecirix NV | Series B | $80M | Mar 2022 |
 Fauna Bio | Seed | $9M | Sep 2021 |
 Noema Pharma | Series A | $59M | Dec 2020 |
| NNeuroVia, Inc. | Series A | $14M | Jul 2017 |
 eFFECTOR Therapeutics | Series B | $40M | Dec 2015 |
Top Co-Investors
Novartis Venture Fund2 shared
INKEF Capital1 shared
Jeito Capital1 shared
Forbion1 shared
Gimv1 shared
HealthCap1 shared
Novo Holdings1 shared
Pontifax1 shared
Nexus Venture Partners1 shared
Altitude Life Science Ventures1 shared
Abingworth1 shared
SR One1 shared
The Column Group1 shared
U.S. Venture Partners1 shared
Astellas Venture Management1 shared
Osage University Partners1 shared
True Ventures1 shared
Lifeforce Capital1 shared
Pacific 8 Ventures1 shared
Vibe Capital1 shared
Last updated: 21 April 2026